Does the media favor NMTC or NYXH?

In the previous week, Nyxoah had 5 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 7 mentions for Nyxoah and 2 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.00 beat Nyxoah's score of -0.48 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroOne Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nyxoah 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer ECOR or NMTC?

In the previous week, electroCore had 6 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 8 mentions for electroCore and 2 mentions for NeuroOne Medical Technologies. electroCore's average media sentiment score of 0.19 beat NeuroOne Medical Technologies' score of 0.00 indicating that electroCore is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral NeuroOne Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer SNWV or NMTC?

In the previous week, Sanuwave Health had 4 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 6 mentions for Sanuwave Health and 2 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.00 beat Sanuwave Health's score of -0.47 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanuwave Health 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroOne Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor NMTC or MDAI?

In the previous week, NeuroOne Medical Technologies and NeuroOne Medical Technologies both had 2 articles in the media. NeuroOne Medical Technologies' average media sentiment score of 0.00 equaled Spectral AI'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroOne Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Spectral AI 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

NeuroOne Medical Technologies (NMTC) Competitors

$1.63 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$1.64 +0.01 (+0.61%)

As of 08/7/2026 07:21 PM Eastern

Compare

NMTC vs. NYXH, ECOR, SNWV, COCH, and MDAI

Should you buy NeuroOne Medical Technologies stock or one of its competitors? MarketBeat compares NeuroOne Medical Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NeuroOne Medical Technologies include Nyxoah (NYXH), electroCore (ECOR), Sanuwave Health (SNWV), Envoy Medical (COCH), and Spectral AI (MDAI). These companies are all part of the "healthcare equipment" industry.

How does NeuroOne Medical Technologies compare to Nyxoah?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Nyxoah (NASDAQ:NYXH) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

NeuroOne Medical Technologies presently has a consensus target price of $11.67, suggesting a potential upside of 615.75%. Nyxoah has a consensus target price of $5.26, suggesting a potential upside of 257.96%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Nyxoah.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

NeuroOne Medical Technologies has a net margin of -68.35% compared to Nyxoah's net margin of -443.16%. NeuroOne Medical Technologies' return on equity of -99.43% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-68.35%	-99.43%	-70.40%
Nyxoah	-443.16%	-178.90%	-81.83%

NeuroOne Medical Technologies has higher revenue and earnings than Nyxoah. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10M	1.17	-$3.61M	-$0.85	N/A
Nyxoah	$11.33M	5.03	-$101.92M	-$2.52	N/A

NeuroOne Medical Technologies has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Nyxoah has a beta of 1.62, indicating that its share price is 62% more volatile than the broader market.

In the previous week, Nyxoah had 5 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 7 mentions for Nyxoah and 2 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.00 beat Nyxoah's score of -0.48 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroOne Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nyxoah	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

NeuroOne Medical Technologies beats Nyxoah on 12 of the 16 factors compared between the two stocks.

How does NeuroOne Medical Technologies compare to electroCore?

electroCore (NASDAQ:ECOR) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

In the previous week, electroCore had 6 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 8 mentions for electroCore and 2 mentions for NeuroOne Medical Technologies. electroCore's average media sentiment score of 0.19 beat NeuroOne Medical Technologies' score of 0.00 indicating that electroCore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
NeuroOne Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

electroCore has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

NeuroOne Medical Technologies has lower revenue, but higher earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than NeuroOne Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	2.28	-$13.97M	-$1.66	N/A
NeuroOne Medical Technologies	$12.10M	1.17	-$3.61M	-$0.85	N/A

26.7% of electroCore shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 7.8% of electroCore shares are held by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

electroCore presently has a consensus price target of $18.00, suggesting a potential upside of 122.50%. NeuroOne Medical Technologies has a consensus price target of $11.67, suggesting a potential upside of 615.75%. Given NeuroOne Medical Technologies' stronger consensus rating and higher possible upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

electroCore has a net margin of -39.96% compared to NeuroOne Medical Technologies' net margin of -68.35%. NeuroOne Medical Technologies' return on equity of -99.43% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
NeuroOne Medical Technologies	-68.35%	-99.43%	-70.40%

Summary

NeuroOne Medical Technologies beats electroCore on 9 of the 16 factors compared between the two stocks.

How does NeuroOne Medical Technologies compare to Sanuwave Health?

Sanuwave Health (NASDAQ:SNWV) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Sanuwave Health has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market.

42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Sanuwave Health has a net margin of 32.38% compared to NeuroOne Medical Technologies' net margin of -68.35%. Sanuwave Health's return on equity of 8,163.31% beat NeuroOne Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	8,163.31%	39.02%
NeuroOne Medical Technologies	-68.35%	-99.43%	-70.40%

In the previous week, Sanuwave Health had 4 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 6 mentions for Sanuwave Health and 2 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.00 beat Sanuwave Health's score of -0.47 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanuwave Health	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeuroOne Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sanuwave Health presently has a consensus price target of $51.00, suggesting a potential upside of 767.35%. NeuroOne Medical Technologies has a consensus price target of $11.67, suggesting a potential upside of 615.75%. Given Sanuwave Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Sanuwave Health is more favorable than NeuroOne Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Sanuwave Health has higher revenue and earnings than NeuroOne Medical Technologies. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	1.15	$11.81M	$0.24	24.50
NeuroOne Medical Technologies	$12.10M	1.17	-$3.61M	-$0.85	N/A

Summary

Sanuwave Health beats NeuroOne Medical Technologies on 14 of the 17 factors compared between the two stocks.

How does NeuroOne Medical Technologies compare to Envoy Medical?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, media sentiment, risk and valuation.

16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 11.8% of NeuroOne Medical Technologies shares are owned by insiders. Comparatively, 7.1% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

NeuroOne Medical Technologies has higher revenue and earnings than Envoy Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10M	1.17	-$3.61M	-$0.85	N/A
Envoy Medical	$240K	215.01	-$23.76M	-$1.01	N/A

NeuroOne Medical Technologies presently has a consensus price target of $11.67, indicating a potential upside of 615.75%. Envoy Medical has a consensus price target of $2.25, indicating a potential upside of 235.22%. Given NeuroOne Medical Technologies' stronger consensus rating and higher possible upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

NeuroOne Medical Technologies has a net margin of -68.35% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat NeuroOne Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-68.35%	-99.43%	-70.40%
Envoy Medical	-9,875.64%	N/A	-177.92%

In the previous week, NeuroOne Medical Technologies had 2 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for NeuroOne Medical Technologies and 0 mentions for Envoy Medical. NeuroOne Medical Technologies' average media sentiment score of 0.00 equaled Envoy Medical'saverage media sentiment score.

Company	Overall Sentiment
NeuroOne Medical Technologies	Neutral
Envoy Medical	Neutral

NeuroOne Medical Technologies has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

Summary

NeuroOne Medical Technologies beats Envoy Medical on 11 of the 15 factors compared between the two stocks.

How does NeuroOne Medical Technologies compare to Spectral AI?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

NeuroOne Medical Technologies has a net margin of -68.35% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat NeuroOne Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-68.35%	-99.43%	-70.40%
Spectral AI	-85.58%	N/A	-72.97%

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by insiders. Comparatively, 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, NeuroOne Medical Technologies and NeuroOne Medical Technologies both had 2 articles in the media. NeuroOne Medical Technologies' average media sentiment score of 0.00 equaled Spectral AI'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroOne Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Spectral AI	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NeuroOne Medical Technologies currently has a consensus price target of $11.67, indicating a potential upside of 615.75%. Spectral AI has a consensus price target of $4.00, indicating a potential upside of 128.57%. Given NeuroOne Medical Technologies' higher probable upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

NeuroOne Medical Technologies has higher earnings, but lower revenue than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than NeuroOne Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10M	1.17	-$3.61M	-$0.85	N/A
Spectral AI	$19.65M	2.83	-$7.57M	-$0.53	N/A

NeuroOne Medical Technologies has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Summary

Spectral AI beats NeuroOne Medical Technologies on 9 of the 15 factors compared between the two stocks.

Get NeuroOne Medical Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NMTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NMTC vs. The Competition

Export

Metric	NeuroOne Medical Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$14.18M	$5.76B	$7.00B	$12.99B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	-1.92	24.26	270.59	25.05
Price / Sales	1.17	68.36	599.45	84.15
Price / Cash	N/A	33.55	28.89	37.44
Price / Book	1.92	6.11	11.21	6.43
Net Income	-$3.61M	$149.01M	$3.45B	$348.10M
7 Day Performance	-4.12%	2.54%	3.41%	2.68%
1 Month Performance	-43.40%	0.78%	-0.71%	-0.83%
1 Year Performance	-63.71%	4.93%	77.31%	23.97%

NeuroOne Medical Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NMTC NeuroOne Medical Technologies	2.2891 of 5 stars	$1.63 flat	$11.67 +615.7%	-63.7%	$14.18M	$12.10M	N/A	20	Upcoming Earnings Gap Down High Trading Volume
NYXH Nyxoah	2.8562 of 5 stars	$1.45 -0.7%	$5.96 +311.2%	-80.2%	$56.59M	$11.33M	N/A	110	News Coverage Earnings Report Analyst Downgrade Gap Down
ECOR electroCore	2.7227 of 5 stars	$6.23 +2.3%	$18.00 +188.9%	+75.1%	$54.91M	$32.03M	N/A	50	Earnings Report Gap Down High Trading Volume
SNWV Sanuwave Health	2.5268 of 5 stars	$6.06 -4.0%	$51.00 +741.6%	-85.2%	$54.26M	$44.05M	18.36	40	Earnings Report Upcoming Earnings
COCH Envoy Medical	2.3726 of 5 stars	$0.69 -0.3%	$2.25 +227.0%	-56.1%	$53.09M	$240K	N/A	34	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NMTC) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NeuroOne Medical Technologies (NMTC) Competitors

NMTC vs. NYXH, ECOR, SNWV, COCH, and MDAI

How does NeuroOne Medical Technologies compare to Nyxoah?

Summary

How does NeuroOne Medical Technologies compare to electroCore?

Summary

How does NeuroOne Medical Technologies compare to Sanuwave Health?

Summary

How does NeuroOne Medical Technologies compare to Envoy Medical?

Summary

How does NeuroOne Medical Technologies compare to Spectral AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NMTC vs. The Competition

NeuroOne Medical Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NeuroOne Medical Technologies (NMTC) Competitors

NMTC vs. NYXH, ECOR, SNWV, COCH, and MDAI

How does NeuroOne Medical Technologies compare to Nyxoah?

Do analysts recommend NMTC or NYXH?

Is NMTC or NYXH more profitable?

Which has better valuation and earnings, NMTC or NYXH?

Which has more volatility & risk, NMTC or NYXH?

Does the media favor NMTC or NYXH?

Do institutionals and insiders hold more shares of NMTC or NYXH?

Summary

How does NeuroOne Medical Technologies compare to electroCore?

Does the media prefer ECOR or NMTC?

Which has more volatility & risk, ECOR or NMTC?

Which has higher earnings and valuation, ECOR or NMTC?

Do institutionals & insiders hold more shares of ECOR or NMTC?

Do analysts recommend ECOR or NMTC?

Is ECOR or NMTC more profitable?

Summary

How does NeuroOne Medical Technologies compare to Sanuwave Health?

Which has more risk and volatility, SNWV or NMTC?

Do insiders and institutionals have more ownership in SNWV or NMTC?

Is SNWV or NMTC more profitable?

Does the media prefer SNWV or NMTC?

Do analysts rate SNWV or NMTC?

Which has stronger earnings and valuation, SNWV or NMTC?

Summary

How does NeuroOne Medical Technologies compare to Envoy Medical?

Do insiders & institutionals have more ownership in NMTC or COCH?

Which has preferable earnings and valuation, NMTC or COCH?

Do analysts rate NMTC or COCH?

Is NMTC or COCH more profitable?

Does the media favor NMTC or COCH?

Which has more risk & volatility, NMTC or COCH?

Summary

How does NeuroOne Medical Technologies compare to Spectral AI?

Is NMTC or MDAI more profitable?

Do institutionals & insiders believe in NMTC or MDAI?

Does the media favor NMTC or MDAI?

Do analysts prefer NMTC or MDAI?

Which has better earnings and valuation, NMTC or MDAI?

Which has more volatility & risk, NMTC or MDAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NMTC vs. The Competition

NeuroOne Medical Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools